STEPHANIE JOHNSON: Open Payments
NPI 1952798019 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 57 payments from 17 companies in 2025. Trend: 2023 $745 · 2024 $962 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $168 |
| ABBVIE INC. | 11 | $163 |
| Abbott Laboratories | 10 | $148 |
| GlaxoSmithKline, LLC. | 6 | $110 |
| Astellas Pharma US Inc | 1 | $98 |
| Lilly USA, LLC | 4 | $65 |
| Dexcom, Inc. | 3 | $57 |
| PFIZER INC. | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Antares Pharma, Inc. | 2 | $32 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, Wegovy, Xtandi, Dexcom G6 Transmitter, SHINGRIX, TRELEGY ELLIPTA, CUVITRU.
Industry payments across GA — which companies pay providers there.
